Realgar-Indigo naturalis formula

DRUG2 trials

Sponsors

First Affiliated Hospital Xi'an Jiaotong University

Conditions

Acute Myeloid LeukemiaAcute Promyelocytic Leukemia

Phase 1

Treatment of Acute Myeloid Leukemia With Arsenic and All-trans Retinoid Acid

First Affiliated Hospital Xi'an Jiaotong UniversityAcute Myeloid Leukemia

Start: 2019-02-03End: 2023-12-31Target: 30Updated: 2022-03-28

Phase 3

Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF)

First Affiliated Hospital Xi'an Jiaotong UniversityAcute Promyelocytic Leukemia

Start: 2016-09-01End: 2022-11-01Target: 110Updated: 2021-09-08

Related Papers

Arsenic trioxide versus Realgar-Indigo naturalis formula in non-high-risk acute promyelocytic leukemia: a multicenter, randomized trial

Haematologica2024-11-07

Oral Realgar-<i>Indigo Naturalis</i> Formula Versus Intravenous Arsenic Trioxide for Non-High-Risk Patients with Acute Promyelocytic Leukemia: Interim Results of a Multicenter Randomized Controlled Trial APL16

Blood2022-11-15

Treatment of non-high-risk acute promyelocytic leukemia with realgar-indigo naturalis formula (RIF) and all-trans retinoid acid (ATRA): study protocol for a randomized controlled trial.

2020-01-024 citations